Antifungal agents in children.

  title={Antifungal agents in children.},
  author={William J Steinbach},
  journal={Pediatric clinics of North America},
  volume={52 3},
  pages={895-915, viii}
Fungal pathogens are an increasingly recognized complication of organ transplantation and the ever more potent chemotherapeutic regimens for childhood malignancies. This article provides a brief overview of the current state of systemic antifungal therapy. Currently licensed drugs, including amphotericin B and its lipid derivates; 5-fluorocytosine; the azoles, including fluconazole, itraconazole, and voriconazole; and a representative of the new class of echinocandin agents, caspofungin, are… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 18 extracted citations


Publications referenced by this paper.
Showing 1-10 of 125 references

A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis

  • DS Krause, AE Simjee, C van Rensburg
  • Clin Infect Dis
  • 2004
1 Excerpt

Similar Papers

Loading similar papers…